Objectıve: High blood pressure is a risk factor for mortality from all causes as well as those from cardiovascular diseases, stroke and heart disease. Non-dipping pattern in hypertensive patients has been shown to be associated with an excess of target organ damage and adverse outcome. Glycated hemoglobin (HbA1c) used for monitoring glucose control in patients with diabetes is a predictor of cardiovascular disease (CVD) and all-cause mortality. The aim of this study was to evaluate the level of HbA1c in dipper and non-dipper hypertensive patients without diabetes. Methods: 114 consecutive hypertensive patients without diabetes 41 healthy subjects as control group had been enrolled in the study. 24-hour Ambulatory blood pressure monitoring allowed to classify 58 patients in non-dipper and 56 patients in dipper groups. Carotid intima-media thickness (CIMT) had been assessed by Doppler ultrasound and the relation between the HbA1c levels and CIMT thickness had been evaluated. Results: Age, gender, BMI and lipid levels did not differ significantly between groups. There was no significant difference between HbA1c levels of control subjects and dipper hypertensive patients (5.18AE0.43; 5.36AE0.39, p¼0.121). The non-dipper patients had significantly higher values of HbA1c levels compared to controls. (5.54AE0.48 versus 5.18AE0.43 p<0,001). The non-dipper patients had a trend to have higher levels of HbA1c compared to dippers but the difference was not significant (5.54AE0.48'e 5.36AE0.39 p¼0,07). CIMT thickness values were significantly higher in nondipper patients compared to both dippers and control group. Background: The phenomenon of masked hypertension (MH) is defined as a clinical condition in which a patient's office blood pressure (BP) level is normal but ambulatory or home BP readings are in the hypertensive range. An increased prevalence of masked hypertension (MHT) has been demonstrated among patients with diabetes mellitus (DM). MHT appears to cause cardiovascular (CV) complications similar to clinically overt hypertension and is associated with increased macrovascular and microvascular complications in patients with DM population. In the light of these findings the aim of this study was to determine the prevalence and determinants of masked hypertension in diabetic patients and evaluate the relationship between HbA1c and MHT in diabetic patients.
Methods: This study included diabetic patients (n¼80) with normal office blood pressure (<130/80 mmHg) with a mean age of 53,6AE10,4 years. None of the participants were using antihypertensive medications. An ambulatory blood pressure monitorization (ABPM) was performed in all participants for 24 hours. HbA1c levels was measured and patients divided into two groups according to HbA1c levels. HbA1c was considered high if >6.5. There was no statistically significant difference about the demographic characteristics between the 2 groups. Masked hypertension was defined in diabetic patients as an office blood pressure(OBP) < 130/80 mmHg and mean ambulatory blood pressure > 125/75 mmHg. Results: 80 diabetic patients had normal office blood pressure, of which 63% diagnosed to have masked hypertension based on established criteria. HbA1c levels were increased in the MHT group when compared normotensive diabetics (%70 in masked HT, %30 in normotansive group). Although this difference was not statistically significant, daily, night and mean systolic blood pressures were high in high HbA1c group (p¼0.015, p¼0.011, p¼0.011). Additionally non-dipper pattern was more prevalant in the group with high HbA1c levels. Conclusıons: A significant fraction of T2DM patients with controlled office blood pressure were diagnosed with MHT. Our results indicate that in patients with impaired blood glucose regulation masked hypertension prevalance is increased. Background: Psoriasis vulgaris is one of the most prevalent chronic, inflammatory skin disorder. Patients with psoriasis carry an excess risk of essential hypertension. Masked hypertension (MH) defined as normal office blood pressure (BP) with elevated ambulatory BP (ABPM) has been drawing attention recently due to its association with increased risk of developing sustained hypertension, cardiovascular morbidity and mortality. The aim of this study is to investigate the prevalence of MH in psoriatic patients. Materıals-Methods: One hundred and ten middle-aged, normotensive, non-obese patients with psoriasis vulgaris (group 1) and 110 age-and gender matched normotensive controls (group 2) were included in the study. ABPM was performed in all participants over a 24-h period. The clinical severity of the disease was determined according to the current indexes. Results: The main characteristics and laboratory findings of patients were summarized in Table 1 . Both groups were similar in terms of age, gender, anthropometric measures such as BMI, waist and hip circumferences, and laboratory measures of lipid profile and fasting glucose. The night-time and 24-hour average BP values (SBP, DBP and MABP) and daytime SBP were significantly higher in patients with psoriasis vulgaris compared to the control subjects ( Table 2 ). The prevalence of MH among subjects with psoriasis vulgaris was 31.8% and increased compared to control subjects (p<0.01) (Figure 1 ). Male gender, waist circumference, and diffuse psoriatic involvement were detected as independent predictors of MH. Conclusıons: MH is prevalent in patients with psoriasis vulgaris. Assessment with ABPM and close follow-up for development of hypertension is reasonable. Baseline characteristics and laboratory findings of the study population.
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